An autologous cell therapy batch is one patient, one product, and a vein-to-vein clock that does not stop. Chain of identity has to be proven at every handoff, from apheresis receipt through selection, activation, expansion, formulation, freeze, and release, and a single break is a lost dose.
Manufacturing execution and QC release happen in parallel under time pressure, and most systems handle one or the other. The batch record is on paper or in a generic MES, the release tests are in a LIMS, and the COI trail is in a third place. Reconciling three systems takes time this batch does not have.
Labbit runs the batch record and the release tests on the same platform. Patient-lot identity is enforced at every scan, instrument runs from Prodigy and Sepax attach to the batch, expansion trends update daily, and release tests aggregate against the infusion date. Orca Bio manufactures on Labbit.